Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

A Rapid Assessing Method of Drug Susceptibility Using Flow Cytometry for Mycobacterium tuberculosis Isolates Resistant to Isoniazid, Rifampin, and Ethambutol

  • Lee, Sun-Kyoung (Division of Immunopathology and Cellular Immunology, International Tuberculosis Research Center) ;
  • Baek, Seung-Hun (Department of Microbiology, Yonsei University College of Medicine) ;
  • Hong, Min-Sun (Division of Immunopathology and Cellular Immunology, International Tuberculosis Research Center) ;
  • Lee, Jong-Seok (Division of Microbiology, International Tuberculosis Research Center) ;
  • Cho, Eun-Jin (Division of Microbiology, International Tuberculosis Research Center) ;
  • Lee, Ji-Im (Division of Microbiology, International Tuberculosis Research Center) ;
  • Cho, Sang-Nae (Department of Microbiology, Yonsei University College of Medicine) ;
  • Eum, Seok-Yong (Division of Immunopathology and Cellular Immunology, International Tuberculosis Research Center)
  • Received : 2021.09.27
  • Accepted : 2022.02.22
  • Published : 2022.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: The current conventional drug susceptibility test (DST) for Mycobacterium tuberculosis (Mtb) takes several weeks of incubation to obtain results. As a rapid method, molecular DST requires only a few days to get the results but does not fully cover the phenotypic resistance. A new rapid method based on the ability of viable Mtb bacilli to hydrolyze fluorescein diacetate to free fluorescein with detection of fluorescent mycobacteria by flow cytometric analysis, was recently developed. Methods: To evaluate this cytometric method, we tested 39 clinical isolates which were susceptible or resistant to isoniazid (INH) or rifampin (RIF), or ethambutol (EMB) by phenotypic or molecular DST methods and compared the results. Results: The susceptibility was determined by measuring the viability rate of Mtb and all the isolates which were tested with INH, RIF, and EMB showed susceptibility results concordant with those by the phenotypic solid and liquid media methods. The isolates having no mutations in the molecular DST but resistance in the conventional phenotypic DST were also resistant in this cytometric method. These results suggest that the flow cytometric DST method is faster than conventional agar phenotypic DST and may complement the results of molecular DST. Conclusion: In conclusion, the cytometric method could provide quick and more accurate information that would help clinicians to choose more effective drugs.

Keywords

Acknowledgement

This study was supported by the "Korea Disease Control and Prevention Agency, Republic of Korea".

References

  1. World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization; 2019.
  2. Woods GL, Brown-Elliott BA, Conville PS, Desmond EP, Hall GS, Lin G, et al. Susceptibility testing of mycobacteria, Nocardiae, and other aerobic actinomycetes. Report No. M24-A2. Wayne: Clinical and Laboratory Standards Institute; 2011.
  3. Miotto P, Zhang Y, Cirillo DM, Yam WC. Drug resistance mechanisms and drug susceptibility testing for tuberculosis. Respirology 2018;23:1098-113. https://doi.org/10.1111/resp.13393
  4. Koh WJ, Ko Y, Kim CK, Park KS, Lee NY. Rapid diagnosis of tuberculosis and multidrug resistance using a MGIT 960 system. Ann Lab Med 2012;32:264-9. https://doi.org/10.3343/alm.2012.32.4.264
  5. Palomino JC, Martin A, Von Groll A, Portaels F. Rapid culture-based methods for drug-resistance detection in Mycobacterium tuberculosis. J Microbiol Methods 2008;75:161-6. https://doi.org/10.1016/j.mimet.2008.06.015
  6. O'Grady J, Maeurer M, Mwaba P, Kapata N, Bates M, Hoelscher M, et al. New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis. Curr Opin Pulm Med 2011;17:134-41. https://doi.org/10.1097/MCP.0b013e3283452346
  7. Wells WA, Boehme CC, Cobelens FG, Daniels C, Dowdy D, Gardiner E, et al. Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action. Lancet Infect Dis 2013;13:449-58. https://doi.org/10.1016/S1473-3099(13)70025-2
  8. Xie YL, Chakravorty S, Armstrong DT, Hall SL, Via LE, Song T, et al. Evaluation of a rapid molecular drug-susceptibility test for tuberculosis. N Engl J Med 2017;377: 1043-54. https://doi.org/10.1056/NEJMoa1614915
  9. Zhang Y, Yew WW. Mechanisms of drug resistance in Mycobacterium tuberculosis . Int J Tuberc Lung Dis 2009;13:1320-30.
  10. Gygli SM, Borrell S, Trauner A, Gagneux S. Antimicrobial resistance in Mycobacterium tuberculosis : mechanistic and evolutionary perspectives. FEMS Microbiol Rev 2017;41:354-73. https://doi.org/10.1093/femsre/fux011
  11. Norden MA, Kurzynski TA, Bownds SE, Callister SM, Schell RF. Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry. J Clin Microbiol 1995;33:1231-7. https://doi.org/10.1128/jcm.33.5.1231-1237.1995
  12. Bownds SE, Kurzynski TA, Norden MA, Dufek JL, Schell RF. Rapid susceptibility testing for nontuberculosis mycobacteria using flow cytometry. J Clin Microbiol 1996;34:1386-90. https://doi.org/10.1128/jcm.34.6.1386-1390.1996
  13. Kirk SM, Schell RF, Moore AV, Callister SM, Mazurek GH. Flow cytometric testing of susceptibilities of Mycobacterium tuberculosis isolates to ethambutol, isoniazid, and rifampin in 24 hours. J Clin Microbiol 1998;36:1568-73. https://doi.org/10.1128/JCM.36.6.1568-1573.1998
  14. Reis RS, Neves I Jr, Lourenco SL, Fonseca LS, Lourenco MC. Comparison of flow cytometric and Alamar Blue tests with the proportional method for testing susceptibility of Mycobacterium tuberculosis to rifampin and isoniazid. J Clin Microbiol 2004;42:2247-8. https://doi.org/10.1128/JCM.42.5.2247-2248.2004
  15. Fredricks BA, DeCoster DJ, Kim Y, Sparks N, Callister SM, Schell RF. Rapid pyrazinamide susceptibility testing of Mycobacterium tuberculosis by flow cytometry. J Microbiol Methods 2006;67:266-72. https://doi.org/10.1016/j.mimet.2006.03.020
  16. DeCoster DJ, Vena RM, Callister SM, Schell RF. Susceptibility testing of Mycobacterium tuberculosis: comparison of the BACTEC TB-460 method and flow cytometric assay with the proportion method. Clin Microbiol Infect 2005;11:372-8. https://doi.org/10.1111/j.1469-0691.2005.01127.x
  17. Hendon-Dunn CL, Doris KS, Thomas SR, Allnutt JC, Marriott AA, Hatch KA, et al. A flow cytometry method for rapidly assessing Mycobacterium tuberculosis responses to antibiotics with different modes of action. Antimicrob Agents Chemother 2016;60:3869-83. https://doi.org/10.1128/AAC.02712-15
  18. Goossens SN, Sampson SL, Van Rie A. Mechanisms of drug-induced tolerance in Mycobacterium tuberculosis. Clin Microbiol Rev 2020;34:e00141-20.
  19. Bellerose MM, Baek SH, Huang CC, Moss CE, Koh EI, Proulx MK, et al. Common variants in the glycerol kinase gene reduce tuberculosis drug efficacy. mBio 2019;10:e0063-19.
  20. Safi H, Gopal P, Lingaraju S, Ma S, Levine C, Dartois V, et al. Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance. Proc Natl Acad Sci U S A 2019;116:19665-74. https://doi.org/10.1073/pnas.1907631116
  21. Lim J, Lee JJ, Lee SK, Kim S, Eum SY, Eoh H. Phosphoenolpyruvate depletion mediates both growth arrest and drug tolerance of Mycobacterium tuberculosis in hypoxia. Proc Natl Acad Sci U S A 2021;118:e2105800118. https://doi.org/10.1073/pnas.2105800118